Prodromal Markers in Parkinson’s Disease: Limitations in Longitudinal Studies and Lessons Learned

A growing body of evidence supports a prodromal neurodegenerative process preceding the clinical onset of Parkinson’s disease (PD). Studies have identified several different prodromal markers that may have the potential to predict the conversion from healthy to clinical PD but use considerably diffe...

Descripción completa

Detalles Bibliográficos
Autores principales: Heinzel, Sebastian, Roeben, Benjamin, Ben-Shlomo, Yoav, Lerche, Stefanie, Alves, Guido, Barone, Paolo, Behnke, Stefanie, Berendse, Henk W., Bloem, Bastiaan R., Burn, David, Dodel, Richard, Grosset, Donald G., Hu, Michele, Kasten, Meike, Krüger, Rejko, Moccia, Marcello, Mollenhauer, Brit, Oertel, Wolfgang, Suenkel, Ulrike, Walter, Uwe, Wirdefeldt, Karin, Liepelt-Scarfone, Inga, Maetzler, Walter, Berg, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916171/
https://www.ncbi.nlm.nih.gov/pubmed/27445791
http://dx.doi.org/10.3389/fnagi.2016.00147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916171/
https://www.ncbi.nlm.nih.gov/pubmed/27445791
http://dx.doi.org/10.3389/fnagi.2016.00147

Ejemplares similares